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when the site of surgical reconstruction is exposed to
significant postoperative bacteremia.1 Infections of vas-
cular prostheses after replacement of the thoracic aorta
remain a rare but serious complication with a high mor-
R econstruction or replacement of structures in theheart and proximal aorta is widely used. A danger-
ous and challenging circumstance is present when the
operation is performed during acute endocarditis or
Objective: A porcine model of thoracic aortic graft infection was created,
and various anatomic sites and the timing of inoculation of the graft to
induce infection were investigated. Ultimately, the ability of cryopre-
served allograft to resist infection was compared with that of collagen-
impregnated Dacron graft. Methods: Yorkshire pigs (n = 16) underwent
placement of an expanded polytetrafluoroethylene patch graft in the
ascending aorta and the left atrial appendage (phase I). Eight animals
were immediately given a 50-mL bolus (l · l08 cfu/mL) of Staphylococcus
aureus whereas the other 8 received the infusion 24 hours later. Animals
were put to death 8 weeks later and the grafts were sterilely explanted
and analyzed via microbiologic culture and standard histologic proce-
dures for evidence of infection. The results displayed that the aortic
graft and a delay of induced bacteremia of 24 hours were more reliable
methods of producing infection. During phase II, 13 pigs were random-
ized to receive either a collagen-impregnated Dacron graft (n = 6) or a
cryopreserved allograft (n = 7) in the ascending aortic position only and
infusion of S aureus 24 hours after the operation. The experiment then
proceeded to completion. Results: Phase I results displayed that use of an
aortic graft and induced bacteremia 24 hours after the operation was a
more reliable and reproducible method of producing infection. In phase
II, graft infection was present in 38.5% (5/13) of animals, with only
16.7% (1/6) in the collagen-impregnated Dacron graft group and 57.2%
(4/7) in the cryopreserved allograft group becoming infected. There was
no significant difference between the collagen-impregnated Dacron
graft and cryopreserved allograft groups in the incidences of thoracic
aortic graft infections (P = .27, Fisher exact test). Conclusions: This novel
porcine model of thoracic aortic graft infection is a reproducible method
for the investigation of thoracic aortic graft infections. The phase I study
investigated the timing of the induced bacteremia and the most suscep-
tible position of a graft. Phase II demonstrated that collagen-impreg-
nated Dacron grafts are equivalent, if not superior, to cryopreserved
allografts in resisting central vascular graft infections in the ascending
aorta. (J Thorac Cardiovasc Surg 1999;118:857-65)
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tality.2,3 This condition arises after treatment of
mycotic aneurysms, infected vascular grafts, catheter
induced sepsis, and aortobronchial and aortoenteric fis-
tulas.4 An ideal reconstruction or prosthesis would be
highly resistant to endovascular infection.
Substantial clinical data support the intuitive concept
that reconstruction with autogenous or homologous tis-
sue will resist most bloodstream infections.5-7 These
reports support the use of extra-anatomic revasculariza-
tion with either simultaneous or staged removal of the
entire contaminated prosthesis or the use of cryo-
preserved aortic homograft in the native position.8 This
contrasts with the traditional operative approach to
endocarditis and infectious endarteritis, which is based
on reconstruction with synthetic material. Satisfactory
surgical results, using the traditional technique of pros-
thetic replacement, have been repeatedly observed.9-11
However, this clinical information is not entirely con-
clusive and reflects varied human experience rather
than controlled laboratory observation.
There is no animal model available with which to
examine the surgical treatment of cardiac and proximal
aortic infections. This is in contrast to the established
infrarenal aortic graft infection preparation, which is rel-
evant to abdominal aortic and peripheral vascular graft
infections.12-14 These findings may not be applicable to
the thoracic aorta because of the intrinsically different
properties between the thoracic and abdominal aorta.
The goal of this study was to create a reproducible
animal model for the study of central vascular graft
infections. The porcine model was chosen because it
appears to react to vascular infection in a similar fash-
ion to human beings.15,16 During phase I of the study,
the feasibility of the porcine model and the optimal
positioning and timing of Staphylococcus aureus inoc-
ulation of a graft to induce infection were studied.
Phase II consisted of a comparison of the ability of col-
lagen-impregnated Dacron graft (CIDG) as compared
with cryopreserved porcine allograft (CPA) to resist
infection in the ascending aortic position.
Materials and methods
Animals. Immature Yorkshire pigs of similar ages (approx-
imately 2-4 months) and sizes (15-20 kg) were acclimated to
the SUNY-Brooklyn Research Facility surroundings and pre-
pared for surgery according to the protocol approved by the
SUNY-Brooklyn Institutional Animal Care and Use Com-
mittee in accordance with the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory
Animal Resources, National Research Council, and pub-
lished by the National Academy Press, revised 1996. Each
animal was sedated with ketamine hydrochloride (Ketaset)
2.0 mg/kg intramuscularly and xylazine hydrochloride 2.0
mg/kg intramuscularly and then endotracheally intubated
with a 6F endotracheal tube after induction of anesthesia with
sodium thiopental 5.0 mg/kg. Inhalational anesthesia was
maintained with halothane at a concentration of 0.5% to
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Fig 1. A, Occlusion of the base of the left atrial appendage with a vascular clamp (Satinsky) and resection of atri-
al wall (1 · 2 cm). B, e-PTFE graft in place on the left atrial appendage.
A B
1.0%. Femoral arterial pressure, electrocardiography, and
pulse oximetry were continuously monitored.
Phase I: Studies in optimal positioning and time of inoc-
ulation of the graft. Sixteen animals were used to determine
the optimal placement of grafts to be studied and the timing
of the induced bacteremia. Each animal had a transverse ster-
notomy performed through the 4th intercostal space. The
pericardium was then marsupialized and the animal given an
infusion of heparin sodium (100 U/kg). The base of the left
atrial appendage was transiently occluded with a vascular
clamp (Satinsky), and a small segment (l · 2 cm) was resect-
ed (Fig l, A). A similar size of expanded polytetrafluoroethyl-
ene (e-PTFE) graft* was sutured in place over the defect with
6-0 e-PTFE suture and the clamp was then released (Fig l, B).
A partial occlusion vascular clamp (Satinsky) was then
placed transiently on the mid ascending aorta and a segment
of native aorta was resected (1 · 2 cm) (Fig 2, A). This was
replaced with a similar size of e-PTFE graft material, again
sutured in place with 6-0 e-PTFE suture over the aortic
defect, and the partial occlusion clamp was released (Fig 2,
B). This is similar to the coarctation technique as described
by Cooley.17 The pericardium, sternotomy, and the soft tissue
were closed by means of standard techniques. The animal
was awakened, extubated, and allowed to recover.
The 16 animals were then randomized into 2 groups. Group
1 (n = 8) animals received a 50 mL intravenous bolus of S
aureus (l · 108 colony forming units [cfu]/mL) via a margin-
al ear vein beginning immediately after completion of the
operation and lasting 1 hour. Group 2 (n = 8) animals were
sedated 24 hours after the operation and the same volume and
concentration of S aureus was infused. The S aureus used
throughout the experiment was a biologic control strain of S
aureus (strain No. 25923; American Type Culture Collection,
Rockville, Md). Clonal aliquots of the original strain were
used throughout the study to ensure all animals were receiv-
ing the same bacterial clone.
The animals were evaluated daily for signs of infection,
dehydration, pain, and anorexia by the veterinary staff and
the surgical team. All animals were observed daily for 8
weeks for clinical evidence of infection or sepsis. At the end
of the 8th week both the atrial and aortic grafts were explant-
ed along with a cuff of native tissue by means of sterile tech-
nique. The animals were then put to death by barbiturate
overdose.
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Fig 2. A, Partial occlusion vascular clamp (Satinsky) in place on the mid ascending aorta after which a segment
of native aorta was resected (l · 2 cm). B, e-PTFE graft in place on the mid ascending aorta and left atrial
appendage.
A B
Table I. Grading scale for graft infectious vasculitis 
Histologic grade Definition
0 No or little evidence of infectious vasculitis 
of graft
1 Infectious vasculitis involving less than 10% 
of the graft thickness
2 Infectious vasculitis involving 11% to 25% 
of the graft thickness
3 Infectious vasculitis involving 26% to 50% 
of the graft thickness
4 Infectious vasculitis involving greater than 50% 
of the graft thickness
A histologic grading system was used to quantitate the amount of infectious
vasculitis present in the infected graft.
Methods of analysis. Each graft was transected and one half
(l · 1-cm segment) underwent bacteriologic analysis by means
of standard protocols. This involved placement of the transect-
ed graft in thioglycolate broth. The broth was examined by
trained microbiology technicians. If there was any indication of
bacterial growth in the media, as evidenced by the media
becoming opaque, the broth was plated on a blood agar culture
dish and all bacteria were identified. Microbiologic evidence of
graft infection was defined as explanted graft material growing
only S aureus while in culture. The other one half of each graft
was fixed in 10% formalin for 48 hours and then embedded in
paraffin. Five-micrometer sagittal sections were mounted on
glass slides, and hematoxylin and eosin staining was performed
by means of standard protocols. A histologic grading system
was used to quantitate the amount of infectious vasculitis pre-
sent in the graft (Table I).18 A blinded, experienced pathologist
(Y.D.K.) graded representative slides from each sample.
Histologic evidence of graft infection was defined as a score of
2 or higher. Graft infection was defined as both microbiologic
(positive tissue cultures) and histologic (infectious vasculitis
score of 2 or greater) evidence of graft infection. A mixed
result was defined as one positive and one negative infectious
parameter result.
Phase II: Studies comparing Dacron and aortic allo-
graft response to bacteremia. Phase I results provided a
substrate for phase II of the study, in which 13 pigs under-
went identical graft operations and all received only an
ascending aortic graft in an attempt to determine the ability of
CPA and CIDG to resist infection. Group A (n = 6) animals
were randomized to receive CIDG (Hemashield, Meadox
Medicals, Oakland, NJ) and group B (n = 7) animals were
randomized to receive CPA. The 7 allografts had been har-
vested from the ascending aorta of 3 size- and age-matched
pigs and prepared/cryopreserved according to commercial
protocol (Cryolife, Inc, Marietta, Ga). All animals received
an infusion of the same amount (50 mL), concentration (1 ·
108 cfu/mL), and clonal passage of S aureus 24 hours after
the operation. Animals were put to death 8 weeks after infu-
sion and tissue was examined.
Results
Phase I results displayed a 100% (8/8) mortality for
group 1 animals (induced bacteremia immediately after
the operation), whereas no animals in group 2 (induced
bacteremia 24 hours after the operation) died (P = .001;
as calculated by the Fisher exact test). This portion of
the study also revealed that whereas 75% of the aortic
grafts were consistently infected, in the same animals
only 25% of the left atrial appendage grafts were
infected.
The mortality during phase I of the experiment was
50% (8/16). Group 1 animals (infusion immediately
after the operation) all died (6 died within hours of
infusion and the other 2 died within 1 week of the infu-
sion). All of these animals underwent an uneventful
operation and then displayed respiratory (increased air-
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Table II. Results of aortic versus left atrial appendage graft infections 
Aortic Aortic histology Aortic LAA tissue LAA histology LAA 
Pig tissue culture (grade 0-4) infection culture (grade 0-4) infection
1 + 4 Positive – 1 Negative
2 + 4 Positive – 4 Mixed
3 + 3 Positive + 3 Positive
4 – 1 Negative – 0 Negative
5 – 2 Mixed – 2 Mixed
6 + 4 Positive + 0 Mixed
7 + 3 Positive + 1 Mixed
8 + 3 Positive + 3 Positive
LAA, Left atrial appendage; +, positive tissue culture; –, negative tissue culture; mixed, ± tissue culture and histologic results. Histologic and microbiologic results
of graft tissue are shown. Histologic evidence of graft infection was based on a vasculitis grading scale (Table I) and microbiologic evidence of infection was based
on Staphylococcus aureus only cultured from the harvested tissue.
Table III. CIDGs and CPAs
Graft Graft tissue 
Graft tissue histology Aortic 
Pig material culture (grade 0-4) infection
1 CIDG + 4 Positive
2 CIDG – 1 Negative
3 CIDG – 1 Negative
4 CIDG – 1 Negative
5 CIDG – 1 Negative
6 CIDG – 0 Negative
7 CPA + 4 Positive
8 CPA + 3 Positive
9 CPA + 3 Positive
10 CPA + 2 Positive
11 CPA – 1 Negative
12 CPA – 1 Negative
13 CPA – 0 Negative
CIDG, Collagen-impregnated Dacron graft; CPA, cryopreserved allograft, +,
positive tissue culture; –, negative tissue culture. Histologic and microbiolog-
ic results of graft tissue are given. Histologic evidence of graft infection was
based on a vasculitis grading scale (Table I) and microbiologic evidence of
infection was based on Staphylococcus aureus only cultured from the har-
vested tissue.
way secretions) and cardiac (severe hypotension) com-
plications minutes after the S aureus infusion, which
eventually led to death. Group 2 animals (infusion 24
hours after the operation) all survived to the end of the
study without complication (Fig 3). The difference in
the timing of the infusion of S aureus is a significant
factor of animal survival (P = .001, as calculated by the
Fisher exact test).
Grossly, the grafts from the 8 surviving animals of
group 2 displayed no evidence of aneurysmal dilation
of the native aorta or grafts. These grafts were analyzed
for evidence of infection (Table II). Aortic graft tissue
displayed consistent histologic and microbiologic
proof of infection in 6 of the 8 samples, no evidence of
infection in 1 of the 8, and a mixed result in the remain-
ing sample. In the same 8 animals, the left atrial
appendage graft material displayed consistent histolog-
ic and microbiologic proof of infection in 2 of the 8
samples, no evidence of infection in 2 of the 8 samples,
and a mixed result in 4. Both of the animals with
infected left atrial appendage grafts also had infected
aortic grafts. However, 4 of the 6 infected aortic grafts
displayed either mixed left atrial appendage results or
no evidence of infection.
Induced bacteremia performed 24 hours after surgery
and the placement of graft material in the ascending
aorta both appeared to be more reliable and repro-
ducible mechanisms of graft infection.
During phase II of the experiment the mortality rate
was 7.7% (1/13), with 1 animal in the CPA group
(group B) dying of apparent sepsis in the 8th postoper-
ative week. Since this animal died only days before its
planned death, this animal’s data were included in the
study. There were consistent results between the micro-
biologic and histologic grading of infection of the graft
in all of the animals in phase II of the study (Table III).
Grossly, there was no evidence of aneurysmal dilata-
tion of the native aorta or graft. The overall incidence
of infection was 38.5% (5/13). Infection was present in
only 16.7% (1/6) in the CIDG group (group A). One
animal had evidence of both tissue and histologic
infection and the other 5 had neither. The single infect-
ed graft displayed an immense amount of inflammato-
ry tissue, involving more than 50% of the graft thick-
ness. There was also an immense lymphocytic
infiltration of the graft wall (Fig 4, A). The noninfected
CIDGs displayed normal resorption of the graft,
endothelialization, and minimal evidence of graft or
perigraft inflammation (Fig 4, B). Four (57.2%) of the
7 animals with CPAs had infections. The animals with
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Fig 4. A, The singly infected CIDG (phase II; animal 1) dis-
played a significant amount of inflammatory tissue, involving
more than 50% of the graft wall along with an immense lym-
phocytic response (vessel lumen is directed down; hema-
toxylin and eosin stain, magnification 40· ). B, The nonin-
fected CIDGs displayed normal resorption of the graft,
endothelialization, and minimal evidence graft inflammation
(vessel lumen is directed down; hematoxylin and eosin stain,
magnification 40· ).
A
B
Fig 3. Graph showing comparison of survival in animals
given an infusion of Staphylococcus aureus immediately
after the operation (group 1) versus 24 hours after the opera-
tion (group 2).
centage for the CIDG group (17%). This indicates that
CIDG is unlikely to show a higher incidence of infec-
tion than CPA and may be at least equivalent to CPA in
resisting central vascular infections in the thoracic
position. It also indicates a possible trend for CIDG
being superior to CPA.
Furthermore, during phase II of this study we found
that CIDG, infected in 16.7% (1/6) of animals, resists
infection better than e-PTFE in the ascending aorta (P
= 0.047 as calculated by logistic regression) with an
odds ratio of 14.99.
Conclusions
This study shows that the porcine model developed
for the study of thoracic aortic graft infections is a
reproducible model. During the course of the develop-
ment of this model, we chose to study a prosthetic
material, e-PTFE, because it is easily obtainable and
traditionally has an incidence of infection that is high-
er than that of other graft materials.19-21 By using this
material we were more likely to produce infection and
therefore develop a model that would be able to detect
more subtle differences between infection occurrences
in other graft materials. We avoided having antibiotics
become a confounding variable by not giving the ani-
mals perioperative antibiotics. In phase I of the study,
all grafts were harvested 8 weeks after the operation, as
this is the time period required for complete graft
endothelialization to occur.16 It was also determined
that intravenous infusion of a bolus of S aureus is best
accomplished 24 hours after the operation as compared
with immediately after the operation to ensure survival
(0% vs 100% mortality). This is perhaps due to the sig-
862 Rowe et al The Journal of Thoracic and
Cardiovascular Surgery
November 1999
Fig 6. The infection rate of the CIDG was 16.7% whereas
that of the CPA group was 57.2%. There was no significant
difference between the CIDG and CPA groups in the fre-
quency of thoracic aortic graft infections (P = .27, Fisher
exact test).
infected CPAs showed a significant amount of lympho-
cytic infiltration extending into the media of the graft,
ranging between 11% and 49% of the graft thickness
(Fig 5, A). These findings were similar to observations
in the single infected graft in the CIDG group. The non-
infected CPAs showed near normal appearing incorpo-
ration of the graft into the surrounding native aorta (Fig
5, B).
There was no significant difference between the
CIDG and CPA groups in the frequency of thoracic aor-
tic graft infections (P = .27, Fisher exact test) (Fig 6).
The 95% confidence intervals for the CIDG group were
2% and 46%, whereas the 95% confidence intervals for
the CPA group were 32% and 80%. The 95% upper
limit for the CIDG group (ie, 46%) is less than the per-
centage shown by the CPA group (ie, 57%), whereas
the lower limit for CPA (32%) is higher than the per-
A
B
Fig 5. A, The infected cryopreserved allografts showed a sig-
nificant amount of lymphocytic infiltration into the media of
the graft, extending between 11% and 49% of the graft wall
thickness (vessel lumen is directed down; hematoxylin and
eosin stain, magnification 40· ). B, The noninfected CPAs
showed near normal appearing incorporation of the graft into
the native aorta (vessel lumen is directed down; hematoxylin
and eosin stain, magnification 40· ).
nificant impact of both an immediate bacteremia in
addition to the operation, which was too much of an
insult for the animals to tolerate. These animals had an
anaphylactic reaction after induced bacteremia where-
as the animals undergoing delayed bacteremia all sur-
vived. Phase I of this experiment also revealed that an
ascending aortic onlay graft is more susceptible to bac-
teremia and more reliably infected than a left atrial
appendage onlay graft, since the aortic graft was con-
sistently infected in 75% of the surviving animals
whereas the left atrial appendage graft was consistently
infected in only 25% of the animals. The aortic graft
appeared to be a more reliable and reproducible mech-
anism of graft infection than the left atrial appendage
graft.
In this investigation the resistance of various graft
materials to infection in the ascending aorta was exam-
ined. The current data reveal that CIDG is at least
equivalent, if not superior, to CPA in resisting bac-
teremia and central vascular graft infection. Addition-
ally, in phase I of this study we found that e-PTFE graft
placed in the ascending aorta and infected produced a
confirmed infection in 75.0% (6/8) of the grafts.
Furthermore, on the basis of the observed odds ratio of
infection, e-PTFE is almost 15 times more likely to
become infected than CIDG. This may be explained by
the fact that e-PTFE is nonporous and does not allow
migration of monocytes and macrophages in an attempt
to prevent infection. This is unlike CIDG, which is
porous and provides a collagen matrix for the influx of
the body’s immune response.22,23 Collagen provides a
matrix for a variety of cells undergoing the healing and
remodeling process.24 This includes cells involved with
angiogenesis.25 It appears that Dacron impregnated
with collagen would also serve to enhance this process,
which is so prevalent elsewhere in the body. There is no
statistically significant difference between the preva-
lence of infection between e-PTFE (75.0%) and CPA
(57.1%).
In conclusion, postoperative infections developing
after the repair of cardiac structures and defects are dis-
astrous complications. Although prosthetic graft infec-
tion occurs in less than 2% of all vascular reconstruc-
tions, the high morbidity and mortality demands a
search for improved methods of prevention and thera-
py.3,4 Deep-seated infections after reconstructive car-
diovascular surgery pose a serious morbidity and lead
to the highest mortality of any of the common compli-
cations after cardiac surgery.2 Because of the low inci-
dence of vascular graft infections, the design of clinical
studies is difficult, but animal models provide a valu-
able tool. Until now, no animal model had been devel-
oped to evaluate the ability of varying graft materials in
the proximal aortic position to resist infection. As a
result, much of the data are anecdotal or based on ret-
rospective clinical series. This study reports the first
reproducible animal model for the study of infections
of ascending thoracic aortic grafts. With this model we
demonstrated that CIDGs in the ascending aorta were
equivalent (and possibly superior) to CPAs in resisting
infections caused by bacteremia. This model may have
implications in the study of infectious endocarditis.
Finally, the results of this preliminary study support the
use of this model for the study of various thoracic aor-
tic graft materials and their response to bacteremia.
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Discussion
Dr Paul Kurlansky (Miami Beach, Fla). I congratulate
you on tackling one of the most difficult and interesting prob-
lems in all of thoracic surgery. Your results are very troubling
from a clinical point of view, because conventional wisdom in
clinical studies supports the use of allograft tissue over any
prosthetic tissue in terms of resistance to infection. 
Have you any idea why the Hemashield graft might be
more resistant to infection than the allograft in your model?
Specifically, might the heightened resistance be due to some-
thing in the processing of the Hemashield graft other than just
the collagen impregnation? Does this material undergo some
chemical or other treatment that might make it more resistant
to infection?
Dr Rowe. Thank you very much for the comment. We did
debate that particular point. One of our conclusions was that
the Hemashield, or the CIDG, graft may reflect, to a certain
extent, native tissue. It has collagen, which allows for a
matrix for the natural immune response to take effect, allows
for the ingrowth of lymphocytes, and allows for the migration
of the macrophages to resist infection. Thus it may be more
of a physiologic graft. 
I am not aware of any type of special processing techniques
other than the collagen impregnation of the Dacron graft, but
I can only surmise that it allows more of an immune response
than PTFE, which we also evaluated.
Dr Hazim J. Safi (Houston, Tex). This presentation con-
firms the findings we made with the late Dr Crawford. We did
not use allografts for treating graft infections. I wonder,
though, whether you wrap the Dacron graft with omentum
and what antibiotics you prescribe postoperatively. We con-
tinue to be very happy with the Dacron graft in cases of infec-
tion. We wrap it with omentum and prescribe lifelong anti-
biotic therapy. 
Dr Rowe. In this particular model, we did not use an omen-
tal wrap or a vascularized pedicle graft to try to inhibit infec-
tion. The main purpose of this study was to compare the var-
ious graft materials with as minimal a number of
confounding variables as possible. I am familiar with your
work in the clinical setting. 
The question of lifelong antibiotics is very controversial.
Some centers recommend 6 weeks, 6 months, or even life-
long antibiotics, and that is a subject of controversy. 
Regarding controlled studies, investigating with an animal
wrap is appealing. In addition, we are looking at biomolecu-
lar markers of infection to try to detect graft infection at an
earlier phase than currently available. 
Dr Axel Haverich (Hannover, Germany). We developed an
experimental model of thoracic aortic graft infection a few
years ago, and the data were published in the Journal of
Vascular Surgery. We used 4 different prosthetic grafts in the
same animal, grafting the descending thoracic aorta. The
Dacron material with and without collagen impregnation
does accumulate the antibiotic in the graft material itself. Our
concept at that time was to use a slow-release antibiotic com-
pound, using fibrin sealant and an aminoglycoside, which
was very successful. 
Therefore, one of the possible explanations for your findings
would be an antibiotic prophylaxis for the first 24 hours. You
might actually have antibiotics concentrated in your Dacron
graft, which is probably not the case with PTFE or homografts.
Did you use prophylactic antibiotics intravenously? 
Dr Rowe. That is a very good point. No, we did not use
prophylactic antibiotics in any of our animals or in any of the
settings. However, you are correct. The literature contains
quite a bit of data showing that grafts impregnated with
antibiotics do resist infection, prevent infection, to a much
greater extent than a standard graft without the antibiotic
impregnation. 
Dr Timothy J. Gardner (Philadelphia, Pa). I sort of feel
the spirit of Dr John Kirklin hovering back here. This is an
experimental study, and the study groups did not show a sig-
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nificant difference. There is a trend, and it is a very provoca-
tive finding, but we do not have firm data here just yet. 
Dr Alain Carpentier (Paris, France). Graft infection may
come from the blood itself but may also come from the sur-
rounding tissue. Have you studied or do you plan to study
infection from the surrounding tissue? 
Second question: You investigated Staphylococcus. Have
you tried other bacteria? 
Dr Rowe. Thank you very much for those comments. We
proved in phase I of the study the efficacy of our model. In
our model we injected bacteria systemically, and we were
hoping that the bacteria would concentrate in the graft. When
we put the animals to death, we did not look at other organs
to see whether they were infected, but we did find consistent
results with regard to the grafts themselves being infected. I
suspect that these results are adequate, because the literature
contains quite a bit of information showing that a graft, espe-
cially a prosthetic graft, is a potential site for bacteria to
localize even 2 to 3 weeks after graft placement, so long as
the graft is not endothelialized.
With regard to investigating other microbiologic agents, we
did not use any agent other than S aureus, because we want-
ed to develop a model with one of the more commonly impli-
cated bacteria in graft infection. 
Dr John E. Mayer, Jr (Boston, Mass). One thought
occurred to me in looking at your groups. What you have
done is compare a porous versus a nonporous type of graft
material. Certainly the homograft is nonporous in compar-
ison with e-PTFE. Have you evaluated tissue ingrowth or
vascularization in the wall of the graft? If so, is there any
relationship between that and the susceptibility to infec-
tion? Certainly in almost all other models of infection the
vascular supply to the tissue increases its resistance to
infection.
Dr Rowe. That is actually a very insightful comment. I
agree that these are 2 different types of grafts, basically
porous and nonporous. I am not sure I necessarily agree with
your statement that a homograft is a nonporous type of graft.
I believe any graft, Dacron included and collagen included,
that allows ingrowth or the native immune response to take
place would resist infection. We did not evaluate vascularity,
but I suspect that if the immune response were increased, the
vessels would be the most probable source to transport the
lymphocytes and various cells to the tissue. 
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